Movement Alert｜Boston Scientific Rises 3.29% Overnight, Q2 Earnings Beat and Restructuring Plan Sustain Recovery Momentum

Market Focus09:59

On August 14, Boston Scientific rose 3.29% overnight, trading at $53.39/share, with turnover of $610,400.

On the news front, the company previously reported Q2 adjusted EPS of $0.86, exceeding the market consensus of $0.83, while net sales of $5.44 billion also topped the $5.36 billion estimate. Additionally, Boston Scientific disclosed a global restructuring program expected to incur $700 million to $800 million in pre-tax charges, targeting approximately $500 million in annualized pre-tax cost savings through supply chain optimization and headcount reduction, with substantial completion expected by end of 2029. The company plans to reinvest a substantial portion of savings into growth initiatives. Despite lowering full-year adjusted EPS guidance to $3.28-$3.32 versus the $3.36 consensus, driven by Watchman device slowdown and electrophysiology competition, multiple institutions including Deutsche Bank and RBC maintained buy ratings with adjusted price targets. The current share price continues its post-earnings recovery trajectory.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1162916054?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 09:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162916054","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Boston Scientific Rises 3.29% Overnight, Q2 Earnings Beat and Restructuring Plan Sustain Recovery Momentum","media":"Market Focus","content":"<p><p>On August 14, Boston Scientific rose 3.29% overnight, trading at $53.39/share, with turnover of $610,400.</p><p>On the news front, the company previously reported Q2 adjusted EPS of $0.86, exceeding the market consensus of $0.83, while net sales of $5.44 billion also topped the $5.36 billion estimate. Additionally, Boston Scientific disclosed a global restructuring program expected to incur $700 million to $800 million in pre-tax charges, targeting approximately $500 million in annualized pre-tax cost savings through supply chain optimization and headcount reduction, with substantial completion expected by end of 2029. The company plans to reinvest a substantial portion of savings into growth initiatives. Despite lowering full-year adjusted EPS guidance to $3.28-$3.32 versus the $3.36 consensus, driven by Watchman device slowdown and electrophysiology competition, multiple institutions including Deutsche Bank and RBC maintained buy ratings with adjusted price targets. The current share price continues its post-earnings recovery trajectory.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Boston Scientific Rises 3.29% Overnight, Q2 Earnings Beat and Restructuring Plan Sustain Recovery Momentum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Boston Scientific Rises 3.29% Overnight, Q2 Earnings Beat and Restructuring Plan Sustain Recovery Momentum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-14 09:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 14, Boston Scientific rose 3.29% overnight, trading at $53.39/share, with turnover of $610,400.</p><p>On the news front, the company previously reported Q2 adjusted EPS of $0.86, exceeding the market consensus of $0.83, while net sales of $5.44 billion also topped the $5.36 billion estimate. Additionally, Boston Scientific disclosed a global restructuring program expected to incur $700 million to $800 million in pre-tax charges, targeting approximately $500 million in annualized pre-tax cost savings through supply chain optimization and headcount reduction, with substantial completion expected by end of 2029. The company plans to reinvest a substantial portion of savings into growth initiatives. Despite lowering full-year adjusted EPS guidance to $3.28-$3.32 versus the $3.36 consensus, driven by Watchman device slowdown and electrophysiology competition, multiple institutions including Deutsche Bank and RBC maintained buy ratings with adjusted price targets. The current share price continues its post-earnings recovery trajectory.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSX","symbol_name":"波士顿科学","start_time":0,"source_url":"","article_id":"1162916054","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162916054","pubTimestamp":1786672787,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 14, Boston Scientific rose 3.29% overnight, trading at $53.39/share, with turnover of $610,400.On the news front, the company previously reported Q2 adjusted EPS of $0.86, exceeding the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BSX":"波士顿科学"},"translate_title":"走势警报|波士顿科学隔夜上涨3.29%，第二季度盈利超出预期，重组计划维持复苏势头","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":1},"content_text":"On August 14, Boston Scientific rose 3.29% overnight, trading at $53.39/share, with turnover of $610,400.On the news front, the company previously reported Q2 adjusted EPS of $0.86, exceeding the market consensus of $0.83, while net sales of $5.44 billion also topped the $5.36 billion estimate. Additionally, Boston Scientific disclosed a global restructuring program expected to incur $700 million to $800 million in pre-tax charges, targeting approximately $500 million in annualized pre-tax cost savings through supply chain optimization and headcount reduction, with substantial completion expected by end of 2029. The company plans to reinvest a substantial portion of savings into growth initiatives. Despite lowering full-year adjusted EPS guidance to $3.28-$3.32 versus the $3.36 consensus, driven by Watchman device slowdown and electrophysiology competition, multiple institutions including Deutsche Bank and RBC maintained buy ratings with adjusted price targets. The current share price continues its post-earnings recovery trajectory.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1162916054","isCrawlerRequest":true}